Dr. Julie
Rosenberg
A Global Leader in Biopharma
Julie Rosenberg, MD solves complex global drug development problems for biopharma companies, bringing her deep leadership and executive experience to help organizations solve challenges related to trial design, clinical development pathways, pharmacovigilance, medical strategy, operational efficiencies, regulatory submissions and more.
Rosenberg
Career Highlights
Unparalleled Experience
From Boehringer Ingelheim, Bristol Myers Squibb, Bayer Healthcare, and Pfizer, to countless small- and medium-sized biopharma companies, Dr. Rosenberg’s profound industry knowledge and diverse skill sets help organizations solve the most complex challenges in global drug development.
Global Drug Development Excellence
Dr. Rosenberg has a proven track record working across borders and languages with biopharma companies and health authorities including FDA, EMA, and PMDA to support successful drug development. Her work spans the spectrum from inception of a molecule through key regulatory milestones and product launch.
Pioneering Pharmacovigilance Solutions
Having built a pharmacovigilance program from the ground up, Dr. Rosenberg is skilled in delivering both comprehensive pharmacovigilance solutions and day-to-day drug safety support for biopharma organizations. She can provide pharmacovigilance oversight throughout the product lifecycle to help companies in ensuring patient safety.
Highly-Effective Leadership
Few consultants match Dr. Rosenberg’s leadership experience. She has led cross-functional teams and global programs across clinical development and pharmacovigilance in the biopharma industry. Her leadership style fosters collaboration, adaptability, and clear communication, in turn enabling teams to effectively navigate complex challenges. She is widely recognized for her ability to drive results and maintain focus under high-stakes and demanding conditions.
Drug Consultancy
Biotech and Pharmaceutical Consulting
Dr. Julie Rosenberg, senior life sciences consultant, helps companies navigate the complexities of global drug development. She brings a rare combination not only of deep clinical acumen, but also of regulatory expertise, operational execution, and strategic foresight. Whether guiding the development of a molecule from inception through regulatory approval or building mission-critical de novo pharmacovigilance programs, Dr. Rosenberg has a track record of delivering results in high-stakes environments. Her ability to bridge day-to-day technical expertise with executive-level decision-making makes her an invaluable partner for companies looking to optimize their drug development or pharmacovigilance programs.
Consultant
Reviews
Testimonials
Dr Julie Rosenberg has been an invaluable consultant in our BioBridges team since 2019. Dr. Rosenberg consistently goes above and beyond to provide outstanding support to our clients including medical monitoring, clinical development oversight, pharmacovigilance, and interim Chief Medical Officer. Her professionalism, attention to detail, and strong communication skills make her an invaluable asset to our team. I highly recommend Dr. Rosenberg for any client seeking medical oversight expertise within clinical development and pharmacovigilance.
– Sandrine Tokoto Sr. Director of Career Management BioBridges
Dr. Julie Rosenberg is an experienced pharmaceutical development physician with a strong background in Clinical Hematology and Transplantation Medicine. Julie is well versed in regulatory affairs and has been an invaluable partner in interactions with the FDA and in BLA submission planning. She has a professional and collaborative interpersonal manner and can contribute value across the board in both Biotech and large Pharma.
– William Pullman, MD Senior Advisor and former Interim Chief Medical Officer Omeros Corporation
Dr. Julie Rosenberg is a true subject matter expert on aspects of clinical trial design, implementation, and interpretation and brings a level of professionalism that is hard to find. She demonstrates full command of clinical pharmacology, safety, and analysis of Phase 1 data. She has twenty years of experience as a physician and biotech operator, whitch gives her a dynamic perspective on the nuanced issues of drug development.
– William Bonificio Chief Business Officer Sera Medicines
Dr. Julie Rosenberg filled an essential gap for our startup, guiding, developing and leading a new Pharmacovigilance department. Her outstanding leadership, organization, and team collaboration were essential to maintain appropriate safety oversight of our novel anti-infective programs.
– Paul Eckburg, MD Former Chief Medical Officer AN2 Therapeutics
Dr. Julie Rosenberg is one of our go-to-experts in supporting complex and challenging clinical development initiatives for our clients. She carries deep industry knowledge, strategic problem solving, professionalism and consistently delivers outstanding solutions and results for our clients. Dr. Rosenberg’s ability to translate challenges into opportunities makes her an invaluable asset to any project in the clinical development space.
– Oliver Tsay Vice President BioBridges
Consultant & Coach
About Dr. Rosenberg
Julie Rosenberg, MD is an experienced life sciences leader with a proven track record of success in leading global drug development and pharmacovigilance programs. As a highly skilled pediatric hematologist-oncologist and accomplished business leader, she partners with biopharma companies—from startups to established enterprises—to solve complex challenges in clinical development, trial design, operational efficiency and regulatory strategy.
Dr. Rosenberg provides high-level strategic oversight as well as a wealth of on-the-ground expertise in areas such as medical monitoring, data review, protocol development, and drafting clinical study reports. She frequently leverages her deep insight to support company interactions with global regulatory authorities, including the FDA and EMA. Her ability to balance high-level strategic vision with tactical execution makes her an invaluable asset to any biopharma team.
Recognized for her leadership and impact, Dr. Rosenberg is an invited member of both the Marshall Goldsmith ‘MG’ 100—a select group of top consultants, coaches, and entrepreneurs— and the International Women’s Forum, a global organization of influential female leaders dedicated to driving progress and change. She lives in Southwest Florida with her family.
Ready to Acheive Results?
Contact
Dr. Rosenberg
Quick Links
Julie Rosenberg, MD is a senior life sciences consultant with a proven track record of success in leading global drug development and pharmacovigilance programs.
Contact Details
Email:
Contact Julie Here
© Copyright 2025, Dr. Julie Rosenberg. All Rights Reserved.
Site by: